Not Signed In - The Timing Of Administration Of Platelet-Inhibiting Drugs
Tue, 20 Feb 2007 04:00 AM EST
... Clinicians should carefully weigh the risks and benefits of when to administer platelet glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibitors for patients with acute coronary syndromes undergoing invasive treatment, according to a study in JAMA. [click link for full article] ...
Related Topics
- Platelet Count
- Platelet Function
- Iohexol (oral/rectal administration)
- Platelet dysfunction
- Low Platelet Count
- Acquired platelet function defect
- Congenital platelet function defects
- Anticancer Drugs
- Date Rape Drugs
- Neuropathy secondary to drugs
- Side effects from drugs such as amphotericin B
- Disease-modifying anti-rheumatoid drugs
- Kidney impairment (from drugs used to treat the condition)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Low white blood cell count (from drugs used to treat the condition)
- Social Security
- Veterans
- Traffic Safety
- Developmental Disabilities & Disorders
- Developmental Disabilities
email this page
print this page
bookmark this page
feedback on this page
